HOME >> BIOLOGY >> NEWS
The next generation of scientists recognized at Johns Hopkins

The best of the best. The cream of the crop. Clichs may accurately describe the winners of this year's Young Investigators' Day awards at The Johns Hopkins University School of Medicine, but their work is anything but run of the mill.

Now in its 25th year, Young Investigators' Day recognizes the substantial contributions of all graduate school and medical students, postdoctoral fellows and medical residents and fellows throughout the school of medicine and hospital by rewarding the advances of some of Hopkins' most talented researchers in training.

This year's winning projects have brought a new anti-cancer drug to clinical trial, shown a common diagnostic observation not to be diagnostic at all and turned more than one scientific field on its head. The award recipients will present their study results and accept their awards April 11, beginning at 4 p.m. in Mountcastle Auditorium in the medical school's Preclinical Teaching Building.

"Young investigators are the heart and soul of the research enterprise," says Paul Talalay, M.D., a driving force in the creation of Young Investigators' Day back in 1978 and a continuing supporter. "Each year we take part in an extraordinary intellectual feast, really, in which our young investigators tell the larger Hopkins community about their discoveries. So many wonderful new ideas are presented, and a sense of happy excitement surrounds it."

The results of more than a few of the recognized projects have been or are about to be published in leading journals such as Cell, Science, Nature, The Lancet and The New England Journal of Medicine. But while publication in such journals validates the efforts of a budding scientist or research physician, recognition within Hopkins -- not to mention the award checks -- can be an important boost for young investigators.

"Having my work accepted for publication is a great feeling, but receiving recognition from people I know and have a great deal
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
9-Apr-2002


Page: 1 2 3

Related biology news :

1. Phase II trials of second-generation antisense cancer drug planned following successful early study
2. Disruption of protein-folding causes neurodegeneration, mental retardation
3. Double-segment periodicity underlies odd segment generation in centipedes
4. Gene defects found in age-related macular degeneration
5. UNC scientists discover molecular pathway leading to nerve growth and regeneration
6. Two billion vulnerable to floods by 2050; number expected to double or more in two generations
7. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
8. Land Regeneration Network celebrates first year success
9. Regeneration of injured muscle from adult stem cells
10. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
11. Treatment stimulates growth and regeneration of injured adult skeletal muscle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology:
Cached News: